< Back to all Breaking News
OGXI
12/19/2014 08:12am
OncoGenex Phase 2 Borealis-1 trial resulted in 50% reduction in risk of death 
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.
